aRenal Division, University Hospital, Zurich, Switzerland
bCytos Biotechnology AG, Zurich–Schlieren, Switzerland
cDivision of Angiology and Hypertension, CHUV, Lausanne, Switzerland
dInterdisciplinary group of Molecular Immunopathology, Dermatology/Medical Immunology, Berlin
eInstitute of Medical Immunology, Charite, Berlin
fCharité Research Organisation, Berlin, Germany
*The first three authors contributed equally to this work.
Received 15 May, 2006
Revised 17 August, 2006
Accepted 21 August, 2006
Correspondence and requests for reprints to Martin F. Bachmann, Cytos Biotechnology AG, Wagistrasse 25, 8952 Schlieren, Switzerland Tel: +41 44 7334747; fax: +41 44 7334740; e-mail: [email protected]
Conflicts of interest: P.M.A., J.N., R.S., H-D.V. and F.W. have received research funding from Cytos Biotechnology AG. A.C.T., A.F., P.M., C.S., K.S., K.R., T.P., M.R., P.M., G.T.J. and M.F.B. are employees of Cytos Biotechnology AG and have stock options or stock holdings in Cytos.
Part of this work has been presented as an abstract at the scientific sessions of the American Heart Association 2005 (no. 2445, Circulation 2005; 112:II–511).
